Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 913–936 of 3,978 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Pathophysiology Clear all

Conditions: Hematopoietic Cell Transplantation
Interventions: Biorepository Trial; Other
Lead sponsor: Duke University; Other
Eligibility: 0 Years to 26 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2028
U.S. locations: 3
States / cities: Rochester, Minnesota • Durham, North Carolina • Houston, Texas

Conditions: Cognitive Decline, Age-Related Memory Disorders, Postoperative Complications, Age-Related Atrophy, Postoperative Cognitive Dysfunction
Interventions: Exercise Intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 60 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Gynaecologic Cancer
Interventions: Nurse Led Sexual Health Clinical Program Intervention; Other
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 30 Years to 65 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Cognitive Impairment, Cognitive Decline, Cognition Disorders in Old Age, Well-Being, Psychological, Inflammation, Cognitive Fun
Interventions: LasoperinTM, Placeo; Dietary Supplement
Lead sponsor: Lindenwood University; Other
Eligibility: 30 Years to 60 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Saint Charles, Missouri

Conditions: Alzheimer Disease, Dementia, Hearing Loss, Cognitive Impairment
Interventions: HEARS-NPS device, HEARS-NPS program; Device · Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Insulin Resistance
Interventions: Metformin; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 12 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Multiple Sclerosis
Interventions: Tysabri ® (Natalizumab); Drug
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Pain, Postoperative, Atrial Fibrillation, Cognitive Dysfunction
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Mild Cognitive Impairment, Alzheimer's Disease
Interventions: Transcranial direct current stimulation (tDCS) Soterix Medical Inc. tDCS unit; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 88 Years
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Mild Cognitive Impairment, NAD
Interventions: Nicotinamide riboside, Sugar Pill; Dietary Supplement
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 65 Years and older
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 2
States / cities: San Antonio, Texas

Conditions: Alzheimer's Disease, Mild Cognitive Impairment
Interventions: Insulin aspart, Placebo; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 50 Years to 89 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Preeclampsia, Preeclampsia Postpartum
Interventions: Eplerenone; Drug
Lead sponsor: Anna Stanhewicz, PhD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Healthy Older Adults Ages 60-89
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 60 Years to 89 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Diabetes Mellitus, Type 2
Interventions: Not listed
Lead sponsor: Sashwati Roy; Other
Eligibility: 40 Years to 60 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Vaginitis, Dyspareunia, Breast Neoplasms
Interventions: Testosterone propionate; Drug
Lead sponsor: University of Vermont; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2011
U.S. locations: 2
States / cities: Pawtucket, Rhode Island • Burlington, Vermont

Conditions: Non-alcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, NAFLD, Metabolic Dysfunction-associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis
Interventions: Efinopegdutide, Placebo; Combination Product
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 85 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 33
States / cities: Chandler, Arizona • Flagstaff, Arizona • Peoria, Arizona + 27 more

Conditions: Dementia, Cognitive Impairment, Alzheimer Disease
Interventions: IADLSys system; Diagnostic Test
Lead sponsor: Bijan Najafi, PhD; Other
Eligibility: 50 Years to 95 Years
Enrollment: 64 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Kidney Disease
Interventions: Allopurinol, Placebo; Drug · Other
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Alzheimer's Disease, Mild Cognitive Impairment, Vascular Dementia, Fronto-temporal Dementia, Primary Progressive Aphasia, Parkinson' Disease Dementia, Mixed Dementia
Interventions: Not listed
Lead sponsor: Exonhit; Industry
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2011
U.S. locations: 3
States / cities: Las Vegas, Nevada • Cleveland, Ohio • Lakewood, Ohio

Conditions: Gastrointestinal Dysfunction
Interventions: Active, Placebo; Dietary Supplement · Other
Lead sponsor: Coconut Goodness Food Products Inc.; Industry
Eligibility: 25 Years to 54 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Preeclampsia
Interventions: Aspirin, Placebo; Drug
Lead sponsor: Anna Stanhewicz, PhD; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Erectile Dysfunction
Interventions: sildenafil, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 21 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 31
States / cities: Huntsville, Alabama • Little Rock, Arkansas • Beverly Hills, California + 26 more

Conditions: Chronic Pancreatitis, Chronic Pain
Interventions: Mesenchymal stem cells, Placebo; Drug · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Autism, Cognition Disorder
Interventions: Donepezil hydrochloride, Increase REM sleep percentage; Drug · Behavioral
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 2 Years to 10 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Search by objective public record fields.

A Prospective Registry of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS).

Prehabilitation Exercise Plus Perioperative Optimization of Senior Health

Improving Sexual Health in Gynecological Cancer Patients

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of LasoperinTM on Cognitive Function in Healthy Adults

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Cardiovascular Effects of Metformin on Obesity

The Effect of Natalizumab (Tysabri) on Sexual Dysfunction in Multiple Sclerosis

BRS and Outcomes in Cardiothoracic Surgery

Promoting Adaptive Neuroplasticity in Mild Cognitive Impairment

The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition

Study of Nasal Insulin to Fight Forgetfulness - Short-Acting Insulin Aspart

Vascular Effects of High-Salt After Preeclampsia

Longitudinal Innate Immunity and Aging Study

Leukocyte Dysfunction in Diabetic Patients.

Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.

A Clinical Study of Efinopegdutide in People With Compensated Cirrhosis Due to Steatohepatitis (MK-6024-017)

An Innovative Platform for Objective Monitoring of Instrumental Activities of Daily Living

Uric Acid and the Endothelium in CKD

Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center

An Efficacy Trial in the Research Area of Gastrointestinal Health & Bloating

Daily Aspirin Treatment After Preeclampsia

A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

The Effect of Donepezil (Aricept(Registered Trademark)) on REM Sleep in Children With Autism